Skip to main content
Annex III Entry 140 17/05/2013

Allyl caproate

Allyl caproate; Allyl hexanoate

Allyl caproate is listed in Annex III and may only be used under the conditions shown in this record.

Restricted substance— Annex III, EU Regulation 1223/2009
Entry: 140

Chemical identity and properties

PubChem 2D chemical structure for CAS 123-68-2
CAS 123-68-2PubChem CID 31266

Allyl caproate

2-Propenyl hexanoate is a fatty acid ester. ChEBI

IUPAC name
prop-2-enyl hexanoate
Molecular formula
C9H16O2
Molecular weight
156.22 g/mol
Exact mass
156.115029749 Da
XLogP3
2.7
Topological polar surface area
26.3 Ų
Hydrogen-bond donors
0
Hydrogen-bond acceptors
2
Covalent units
1
Defined stereocentres
0

Also known as

Allyl hexanoateHexanoic acid, allyl esterFEMA No. 20323VH84A363DNSC-20962RefChem:110871204-642-4Hexanoic acid, 2-propenyl ester
16 more reported names
2-PROPENYL HEXANOATE2-Propenyl n-hexanoateHexanoic acid, 2-propen-1-yl esterAllyl n-caproateprop-2-en-1-yl hexanoateAllylester kyseliny kapronoveAllOCOPenAllyl n-hexanoateallylhexanoateAllyl hexanoate (natural)CCRIS 6549EINECS 204-642-4NSC 20962Allylester kyseliny kapronove [Czech]Hexanoic Acid Allyl EsterBRN 1761920
External database identifiers

Evidence from additional scientific databases

NIH PubChem PUG-View
Exact identifier match31266

Attributed physical-property, hazard, environmental and use annotations.

  • Signal: Danger Source: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: H301 (94.9%): Toxic if swallowed [Danger Acute toxicity, oral]; H311 (97.2%): Toxic in contact with skin [Danger Acute toxicity, dermal]; H315 (13.3%): Causes skin irritation [Warning Skin corrosion/irritation]; H319 (10.3%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H331 (76.4%): Toxic if inhaled [Danger Acute toxicity, inhalation]; H400 (80.2%): Very toxic to aquatic life [Warning Hazardous to the aquatic environment, acute hazard]; H410 (11.8%): Very toxic to aquatic life with long lasting effects [Warning Hazardous to the aquatic environment, long-term hazard]; H411 (14%): Toxic to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard]; H412 (78.8%): Harmful to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard] Source: European Chemicals Agency (ECHA)
  • Precautionary Statement Codes: P261, P262, P264, P264+P265, P270, P271, P273, P280, P301+P316, P302+P352, P304+P340, P305+P351+P338, P316, P321, P330, P332+P317, P337+P317, P361+P364, P362+P364, P391, P403+P233, P405, and P501 (click each P-code to see the statement) Source: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 1663 reports by companies from 38 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. Source: European Chemicals Agency (ECHA)
  • Signal: Danger Source: NITE-CMC
  • GHS Hazard Statements: H227: Combustible liquid [Warning Flammable liquids]; H301: Toxic if swallowed [Danger Acute toxicity, oral]; H311: Toxic in contact with skin [Danger Acute toxicity, dermal] Source: NITE-CMC
  • Precautionary Statement Codes: P210, P262, P264, P270, P280, P301+P316, P302+P352, P316, P321, P330, P361+P364, P370+P378, P403, P405, and P501 (click each P-code to see the statement) Source: NITE-CMC
  • Signal: Danger Source: Hazardous Chemical Information System (HCIS), Safe Work Australia
  • GHS Hazard Statements: H301: Toxic if swallowed [Danger Acute toxicity, oral]; H311: Toxic in contact with skin [Danger Acute toxicity, dermal] Source: Hazardous Chemical Information System (HCIS), Safe Work Australia
  • Precautionary Statement Codes: P262, P264, P270, P280, P301+P316, P302+P352, P316, P321, P330, P361+P364, P405, and P501 (click each P-code to see the statement) Source: Hazardous Chemical Information System (HCIS), Safe Work Australia

Mapped by: Existing checksum-valid CAS to unique PubChem CID match. Retrieved: 2026-08-31. Open source record

Scientific classifications and hazard annotations provide context and do not replace the market-specific regulatory decision shown above.

Additional source coverage and match status
SourceResultChecked
NIH PubChem PUG-ViewExact match2026-08-31

A recorded no-match is useful evidence that the source was checked; it is not a claim that the substance does not exist elsewhere.

Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.

Record details

Other restrictions

Level of free allyl alcohol in the ester should be less than 0.1%

INCI glossary name

Allyl caproate

Chemical name

Allyl caproate; Allyl hexanoate

Regulatory information

Key data

Annex
Entry number
140

Inventory links for Allyl caproate

Inventory Restriction reference
Ref 74253

ALLYL CAPROATE

CAS: 123-68-2
EC: 204-642-4

Direct matches are limited for this record, so nearby entries from Annex III are shown as well.

Annex III 142
Nearby record in the same annex

Allyl octanoate

CAS: 4230-97-1
EC: 224-184-9

What Annex III means for Allyl caproate

Allyl caproate is a restricted substance under Annex III of EU Cosmetics Regulation 1223/2009. Its use in cosmetics is only permitted under the specific conditions set out in the entry above, including applicable concentration limits, product type restrictions and required warning statements.

When including this substance in a formulation, all conditions — maximum concentration, product scope and warning labels — must be met simultaneously. Compliance with one condition does not override the others.

This record is linked to 1 CosIng inventory ingredient for name and identifier cross-reference. The page also surfaces 12 related annex records with overlapping identifiers, annex logic or naming patterns.

Compliance checklist

  • Document conditions of use in the Product Information File (PIF).

Frequently asked questions

Allyl caproate is listed in Annex III of EU Regulation 1223/2009 as a restricted substance. It may only be used under the conditions specified in the entry, including any maximum concentration, product type limitation and required warning statements shown above.

CAS 123-68-2 is the unique numerical identifier assigned to Allyl caproate by the Chemical Abstracts Service. In cosmetic compliance work, the CAS number is used to cross-reference the substance across regulatory databases, raw material specifications and safety assessment reports. Multiple EU annex entries may share the same CAS number if the same substance appears under different conditions or in different annexes.

Use the INCI Checker tool on this site to paste your full ingredient list (INCI) and scan it against all Annex II–VI entries. The tool highlights any ingredients that match restricted, prohibited or allergen-flagged records. This is useful for rapid compliance screening of finished product formulas or raw material declarations.

Source note for Annex III record Allyl caproate

This page summarizes one Annex III record for Allyl caproate from public European Commission cosmetic materials and adds linked inventory or identifier matches when available.

Use this record page to review Annex III conditions for Allyl caproate, but confirm any final regulatory decision against the current official annex wording and source files.

Tools & next steps

Check your formula

Paste a full INCI list to detect Allyl caproate and other flagged EU annex records in one pass.

INCI Checker

Compare entries

Compare Allyl caproate side by side with another annex record to review differences in restrictions, concentrations and annex placement.

Compare

Browse the annex

See all records in Annex III and compare regulatory conditions across substances in this annex.

Open Annex III